Carl White

Has grant

University of Western Australia

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Molecular Pharmacology of chemokines in cancer: towards an endogenous approach

Open Date: 2016-01-01

Close Date:

Grant: Close

Molecular pharmacology of chemokine receptor signalling in cancer

Open Date: 2015-01-01

Close Date: 2019-12-31

Grant: Close

Molecular pharmacology of chemokine receptor signalling in cancer

Open Date: 2015-01-01

Close Date: 2019-12-31

Articles (9)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (10)

Rekhati Abhayawardana

Harry Perkins Institute of Medical Research

AUSTRALIA

View details

Martine Smit

University of Amsterdam

NETHERLANDS

View details

Claudia V. Perez Almeria

University of Amsterdam

NETHERLANDS

View details

Jelle van den Bor

University of Amsterdam

NETHERLANDS

View details

Jeanette Woolard

Associate Professor

University of Nottingham

UNITED KINGDOM

View details

Graham A. Mackay

AUSTRALIA

View details

Nick Bergkamp

University of Amsterdam

NETHERLANDS

View details

Barrie Kellam

Professor of Medicinal Chemistry

University of Nottingham

UNITED KINGDOM

View details

Laura E. Kilpatrick

UNITED KINGDOM

View details

Kevin Pfleger

University in Western Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carl White

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (9)

CXCL17 induces activation of human mast cells via MRGPRX2

CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans

ACTION3 Phase 3 Clinical Trial Assessing the Efficacy and Safety of DMX-200 (Repagermanium): Mid-trial Safety Assessment and Pharmacometric Model-Informed Pediatric Dose Selection

NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET

Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels

Detection of genome-edited and endogenously expressed G protein-coupled receptors

The use of fluorescence correlation spectroscopy to monitor cell surface β2‐adrenoceptors at low expression levels in human embryonic stem cell‐derived cardiomyocytes and fibroblasts

A nanoluciferase biosensor to investigate endogenous chemokine secretion and receptor binding

CRISPR-Mediated Protein Tagging with Nanoluciferase to Investigate Native Chemokine Receptor Function and Conformational Changes

Collaborators (10)

Rekhati Abhayawardana

Martine Smit

Claudia V. Perez Almeria

Jelle van den Bor

Jeanette Woolard

Graham A. Mackay

Nick Bergkamp

Barrie Kellam

Laura E. Kilpatrick

Kevin Pfleger

Make your next move.